Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 7:25:21.104.
doi: 10.7812/TPP/21.104.

Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis

Affiliations

Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis

Ken J Park et al. Perm J. .

Abstract

Introduction: Use of kidney replacement therapy (KRT) prediction models for guiding arteriovenous fistula (AVF) referrals in advanced chronic kidney disease (CKD) is unknown. We aimed to compare a hypothetical approach using a KRT prediction model developed in Kaiser Permanente Northwest to estimated glomerular filtration rate (eGFR) for AVF referrals.

Methods: Our retrospective cohort consisted of patients with stage G4 CKD in Kaiser Permanente Northwest followed by nephrology. Two-year KRT risk was calculated at each nephrology visit up to 2 years from entrance into cohort based on a previously published model. We calculated sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) based on several 2-year KRT risk and eGFR cutoffs for outcome of hemodialysis at 18 months. We compared an approach of AVF referral using 2-year KRT risk and eGFR cutoffs using decision curve analysis.

Results: Two-year KRT risk better discriminated progression to hemodialysis compared to eGFR < 15 mL/min (AUC 0.60 vs 0.69 at 2-year KRT risk > 20% and 0.69 at 2-year KRT risk > 40%, p = 0.003 and 0.006, respectively) but not to eGFR of 20 mL/min (AUC 0.64, p = 0.16 and 0.19, respectively). Decision curve analysis showed that AVF referral guided by 2-year KRT risk score resulted in higher net benefit compared to eGFR at low thresholds for referral.

Conclusion: In stage G4 CKD, a 2-year KRT risk model better predicted progression to KRT at 18 months compared to an eGFR of 15 mL/min but not to 20 mL/min and may improve timely referral for AVF placement in patients at lower thresholds for referral.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement: The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Decision curve analysis illustrating net benefit using 2-year kidney replacement therapy risk score > 20% and 40% and estimated glomerular filtration rate < 15 and 20 mL/min compared to referral of no patients and referral of all patients for arteriovenous fistula placement. eGFR = estimated glomerular filtration rate; KRT = kidney replacement therapy.

References

    1. Mills KT, Xu Y, Zhang W, et al. . A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 2015. Nov;88(5):950–7. DOI: 10.1038/ki.2015.230 - DOI - PMC - PubMed
    1. Lok CE, Huber TS, Lee T, et al. . KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis 2020. Apr;75(4 Suppl 2):S1–S164. DOI: 10.1053/j.ajkd.2019.12.001 - DOI - PubMed
    1. Perl J, Wald R, McFarlane P, et al. . Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011. Jun;22(6):1113–21. DOI: 10.1681/ASN.2010111155 - DOI - PMC - PubMed
    1. Crooks PW, Thomas CO, Compton-Phillips A, et al. . Clinical outcomes and healthcare use associated with optimal ESRD starts. Am J Manag Care 2018. Oct;24(10):e305–11. https://www.ajmc.com/view/clinical-outcomes-and-healthcare-use-associate... - PubMed
    1. Piwko C, Vicente C, Marra L, et al. . The STARRT trial: A cost comparison of optimal vs sub-optimal initiation of dialysis in Canada. J Med Econ 2012. Oct;15(1):96–104. DOI: 10.3111/13696998.2011.630850 - DOI - PubMed